Activation of the PI3K-AKT Pathway by Old World Alphaviruses

被引:25
|
作者
Van Huizen, Eline [1 ]
McInerney, Gerald M. [1 ]
机构
[1] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden
基金
瑞典研究理事会;
关键词
metabolism; apoptosis; autophagy; SEMLIKI-FOREST-VIRUS; PHOSPHATIDYLINOSITOL; 3-KINASE; GLUCOSE-METABOLISM; SINDBIS VIRUS; AUTOPHAGY; REPLICATION; CELLS; AKT; EXPRESSION; COMPLEXES;
D O I
10.3390/cells9040970
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alphaviruses can infect a broad range of vertebrate hosts, including birds, horses, primates, and humans, in which infection can lead to rash, fever, encephalitis, and arthralgia or arthritis. They are most often transmitted by mosquitoes in which they establish persistent, asymptomatic infections. Currently, there are no vaccines or antiviral therapies for any alphavirus. Several Old World alphaviruses, including Semliki Forest virus, Ross River virus and chikungunya virus, activate or hyperactivate the phosphatidylinositol-3-kinase (PI3K)-AKT pathway in vertebrate cells, potentially influencing many cellular processes, including survival, proliferation, metabolism and autophagy. Inhibition of PI3K or AKT inhibits replication of several alphaviruses either in vitro or in vivo, indicating the importance for viral replication. In this review, we discuss what is known about the mechanism(s) of activation of the pathway during infection and describe those effects of PI3K-AKT activation which could be of advantage to the alphaviruses. Such knowledge may be useful for the identification and development of therapies.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Activation of the PI3K/Akt pathway in neuroblastoma
    Sartelet, Herve
    Castaing, Marine
    Fabre, Monique
    Bosq, Jacques
    Rougemont, Anne-Laure
    Michieis, Stefan
    Vassal, Gilles
    VIRCHOWS ARCHIV, 2007, 451 (02) : 130 - 130
  • [32] Activation of the PI3K/Akt pathway in neuroblastoma
    Sartelet, H.
    Castain, M.
    Fabre, M.
    Bosq, J.
    Rougemont, A.
    Michiels, S.
    Vassal, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Selective Inhibition of Regulatory T Cells by Targeting the PI3K-Akt Pathway
    Abu-Eid, Rasha
    Samara, Raed N.
    Ozbun, Laurent
    Abdalla, Maher Y.
    Berzofsky, Jay A.
    Friedman, Kevin M.
    Mkrtichyan, Mikayel
    Khleif, Samir N.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (11) : 1080 - 1089
  • [34] Overgrowth syndromes caused by mosaic mutations in the PI3K-AKT signaling pathway
    Spier, Isabel
    Aretz, Stefan
    MEDIZINISCHE GENETIK, 2017, 29 (03): : 306 - 313
  • [35] INHIBITORS OF PI3K-Akt/PKB-mTOR PATHWAY IN GLIOMA THERAPY
    Jakubowicz-Gil, Joanna
    POSTEPY BIOLOGII KOMORKI, 2009, 36 (02) : 189 - 201
  • [36] Cardamonin inhibits silicosis development through the PI3K-AKT signaling pathway
    Ye, Zhimin
    Niu, Zhiyuan
    Li, Juan
    Li, Zisheng
    Hu, Yongbin
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2024, 285
  • [37] Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome
    Li, Tiantian
    Mo, Hui
    Chen, Wenfeng
    Li, Li
    Xiao, Yao
    Zhang, Jing
    Li, Xiaofang
    Lu, Ying
    REPRODUCTIVE SCIENCES, 2017, 24 (05) : 646 - 655
  • [38] Modulation of LPS-induced inflammation and coagulation by the PI3K-Akt pathway
    Luyendyk, James P.
    Tencati, Michael
    Holscher, Todd
    Mackman, Nigel
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E40 - E40
  • [39] FUNCTIONAL STUDIES AND POTENTIAL THERAPEUTIC APPROACHES IN DISORDERS OF THE PI3K-AKT PATHWAY
    Boccuto, Luigi
    Cascio, Lauren
    Dyment, David
    Jones, Kelly
    Norris, Joy
    Chen, Chin-Fu
    Skinner, Cindy
    Basel-Vanagaite, Lina
    Stevenson, Roger
    Innes, Micheil
    Schwartz, Charles
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (08) : 1725 - 1726
  • [40] Thrombosis inhibited by Corydalis decumbens through regulating PI3K-Akt pathway
    Chen, Song
    Tian, Cai-Bo
    Bai, Li-Yu
    He, Xing-Chao
    Lu, Qing-Yu
    Zhao, Yun-Li
    Luo, Xiao-Dong
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 329